Question 1

What is Parabilis Medicines?

Accepted Answer

Parabilis Medicines is a Entity.

Question 2

How often does Parabilis Medicines appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 32 articles.

Question 3

When was Parabilis Medicines first tracked by Ergen?

Accepted Answer

First tracked on Jun 10, 2026.

Question 4

When was Parabilis Medicines last mentioned in news?

Accepted Answer

Last active on Jul 27, 2026.

Question 5

What is Parabilis Medicines's current news sentiment?

Accepted Answer

Aggregate sentiment score: 60 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Parabilis Medicines in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving Parabilis Medicines?

Accepted Answer

Parabilis Medicines Upsized IPO Priced (Jun 10, 2026, 7 articles).

Question 8

How did the "Parabilis Medicines Upsized IPO Priced" event impact Parabilis Medicines?

Accepted Answer

Parabilis Medicines priced its upsized initial public offering and a concurrent private placement, raising significant capital to fund its biopharmaceutical development. Its stock is expected to begin trading on the Nasdaq-100 Global Select Market.

Question 9

How did the "Scribe Therapeutics upsized IPO closes" event impact Parabilis Medicines?

Accepted Answer

Parabilis Medicines also had a record-setting IPO, reflecting strong investor appetite for biotech.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.